Daniel E Meyers (Daniel Meyers)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 13

Top Topics

Locally Advanced

Systemic Sclerosis

Top Venues

Current oncology (Toronto, Ont.)

Cancer medicine

JCO oncology practice

This page only lists publications with an associated author ORCID identifier.

Publications

Chloe Ah-Ryung Lim, Sunita Ghosh, Hali Morrison, Daniel E Meyers, Igor Stukalin, Marc Kerba, Desiree Hao, Aliyah Pabani
Durvalumab-Associated Pneumonitis in Patients with Locally Advanced Non-Small Cell Lung Cancer: A Real-World Population Study. Current oncology (Toronto, Ont.) 30 (12) (2023)
Chloe Ah-Ryung Lim, Sunita Ghosh, Hali Morrison, Daniel E Meyers, Igor Stukalin, Marc Kerba, Desiree Hao, Aliyah Pabani
Durvalumab-Associated Pneumonitis in Patients with Locally Advanced Non-Small Cell Lung Cancer: A Real-World Population Study. Current oncology (Toronto, Ont.) 30 (12) (2023)
Chloe Ah-Ryung Lim, Sunita Ghosh, Hali Morrison, Daniel E Meyers, Igor Stukalin, Marc Kerba, Desiree Hao, Aliyah Pabani
Durvalumab-Associated Pneumonitis in Patients with Locally Advanced Non-Small Cell Lung Cancer: A Real-World Population Study. Current oncology (Toronto, Ont.) 30 (12) (2023)
Chloe Ah-Ryung Lim, Sunita Ghosh, Hali Morrison, Daniel E Meyers, Igor Stukalin, Marc Kerba, Desiree Hao, Aliyah Pabani
Durvalumab-Associated Pneumonitis in Patients with Locally Advanced Non-Small Cell Lung Cancer: A Real-World Population Study. Current oncology (Toronto, Ont.) 30 (12) (2023)
Chloe Ah-Ryung Lim, Sunita Ghosh, Hali Morrison, Daniel E Meyers, Igor Stukalin, Marc Kerba, Desiree Hao, Aliyah Pabani
Durvalumab-Associated Pneumonitis in Patients with Locally Advanced Non-Small Cell Lung Cancer: A Real-World Population Study. Current oncology (Toronto, Ont.) 30 (12) (2023)
Siddhartha Goutam, Igor Stukalin, Benjamin Ewanchuk, Michael Sander, Philip Q Ding, Daniel E Meyers, Daniel Heng, Winson Y Cheung, Tina Cheng
Clinical Factors Associated with Long-Term Survival in Metastatic Melanoma Treated with Anti-PD1 Alone or in Combination with Ipilimumab. Current oncology (Toronto, Ont.) 29 (10) (2022)
Kristin Wright, Daniel E Meyers, Timothy M Chisamore, Matthew D F McInnes, Sergio Sismondo, Bishal Gyawali, Vinay Prasad, Christopher M Booth
Industry Relationships With Medical Oncologists: Who Are the High-Payment Physicians? JCO oncology practice 18 (7) (2022)
Shantanu O Banerji, Daniel E Meyers, Craig Harlos, David E Dawe
The Role of Immunotherapy in the Treatment of Malignant Pleural Mesothelioma. Current oncology (Toronto, Ont.) 28 (6) (2021)
Heidi A I Grosjean, Samantha Dolter, Daniel E Meyers, Philip Q Ding, Igor Stukalin, Siddhartha Goutam, Shiying Kong, Quincy Chu, Daniel Y C Heng, D Gwyn Bebb, Don G Morris, Winson Y Cheung, Aliyah Pabani
Effectiveness and Safety of First-Line Pembrolizumab in Older Adults with PD-L1 Positive Non-Small Cell Lung Cancer: A Retrospective Cohort Study of the Alberta Immunotherapy Database. Current oncology (Toronto, Ont.) 28 (5) (2021)
Daniel E Meyers, Benjamin S Meyers, Timothy M Chisamore, Kristin Wright, Bishal Gyawali, Vinay Prasad, Richard Sullivan, Christopher M Booth
Trends in drug revenue among major pharmaceutical companies: A 2010-2019 cohort study. Cancer (2021)
Michael S Sander, Igor Stukalin, Isabelle A Vallerand, Siddhartha Goutam, Benjamin W Ewanchuk, Daniel E Meyers, Aliyah Pabani, Don G Morris, Daniel Y C Heng, Tina Cheng
Evaluation of the modified immune prognostic index to prognosticate outcomes in metastatic uveal melanoma patients treated with immune checkpoint inhibitors. Cancer medicine 10 (8) (2021)
Andrea S Fung, Vincent C Tam, Daniel E Meyers, Hao-Wen Sim, Jennifer J Knox, Valeriya Zaborska, Janine Davies, Yoo-Joung Ko, Eugene Batuyong, Haider Samawi, Winson Y Cheung, Richard Lee-Ying
Second-line treatment of hepatocellular carcinoma after sorafenib: Characterizing treatments used over the past 10 years and real-world eligibility for cabozantinib, regorafenib, and ramucirumab. Cancer medicine 9 (13) (2020)
Ahmed A Mostafa, Daniel E Meyers, Chandini M Thirukkumaran, Peter Jianrui Liu, Kathy Gratton, Jason Spurrell, Qiao Shi, Satbir Thakur, Don G Morris
Oncolytic Reovirus and Immune Checkpoint Inhibition as a Novel Immunotherapeutic Strategy for Breast Cancer. Cancers 10 (6) (2018)